Concepedia

Massimo Tilli

MT

Statistics

Publications

8

Citations

765

H-Index

8

Active since

2004

Affiliations

University of Ferrara(Current)

Ospedali Riuniti Marche Nord

Azienda Unità Sanitaria Locale di Ferrara

Ospedale San Giuseppe

Azienda Unità Sanitaria Locale 11 di Empoli

Massimo Tilli is an author at University of Ferrara specializing in oncology, medicine, and chemotherapy.

Publications per year

2004–2015

8

Publications

8

Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.

Giammaria Fiorentini, Camillo Aliberti, Massimo Tilli et al. · PubMed · 2012 · 331 citations

, , +17

Chemoembolization (TACE) of Unresectable Intrahepatic Cholangiocarcinoma with Slow-Release Doxorubicin-Eluting Beads: Preliminary Results

Camillo Aliberti, Giorgio Benea, Massimo Tilli et al. · CardioVascular and Interventional Radiology · 2008 · 119 citations

, , +16

Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.

Camillo Aliberti, Massimo Tilli, Giorgio Benea et al. · PubMed · 2006 · 109 citations

, , +17

Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.

Camillo Aliberti, Giammaria Fiorentini, Pier Carlo Muzzio et al. · PubMed · 2011 · 95 citations

, , +17

Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.

Giammaria Fiorentini, Camillo Aliberti, Alessandro Del Conte et al. · PubMed · 2009 · 68 citations

, , +17

1–5 of 8